Skip to Main Content

Psychiatry

Mood & Anxiety Care

Mood and Anxiety Clinic

The Mood and Anxiety Clinic at the UConn Health is dedicated to providing comprehensive and compassionate care to individuals struggling with mood and anxiety symptoms. Our team of board-certified clinicians strives to provide state-of-the-art care informed by cutting edge research. Our program offers a broad range of treatment options from an array of effective medications and psychotherapy interventions. Our highly skilled and experienced clinicians will work with you in a collaborative manner to develop a personalized treatment plan, a plan tailored to fit your needs.

Our clinic specializes in understanding and treatment of mood and anxiety disorders across the lifespan.

Typical patients range in age from early adulthood to late life with a range of psychiatric illnesses including major depression, bipolar disorder, generalized anxiety disorder, social anxiety disorder, panic disorder, post-traumatic stress disorder, adjustment disorders and depression/anxiety issues due to medical illnesses such as cancer and heart conditions. Patients are seen for ongoing care or for one-time diagnostic evaluation/consultation (second opinion) by our nationally-recognized faculty.

Our Commitment

We are committed to be at the forefront of new and effective treatments of mood and anxiety disorders including latest medications and effective psychotherapeutic interventions. Our program also offers opportunities for participating in innovative research studies for patients that are interested.

We offer personalized, evidence-based, multidisciplinary care, including the following services:

  • A comprehensive medical-psychiatric and psycho-social evaluation
  • Psychophrmacological treatments administered by highly skilled and experienced clinicians specializing in the treatment of mood and anxiety disorders
  • Individual and Group psychotherapy including cognitive-behavioral therapy, interpersonal psychotherapy, insight-oriented psychotherapy and psychodynamic psychotherapy
  • Integrated psychopharmacological and individual psychotherapy

We have access to other services within the UConn Health system. Our faculty can refer patients to these services on an individual basis. These services include:

  • Group psychotherapy for diverse indications, including dialectical-behavioral therapy
  • Ancillary clinical testing including focused neurocognitive evaluation
  • Personalized treatment for substance use disorders
  • Electroconvulsive therapy (ECT) services for inpatient, outpatient and maintenance ECT

Patients requiring more intensive treatments can be referred to our Intensive Outpatient Program (IOP) or Inpatient Clinical Program.

Research Studies

We are currently conducting several research studies that may help to improve understanding of the causes of mood and anxiety disorders and develop novel treatments to manage these illnesses. Some of these studies provide assessment and treatment at no charge and some studies provide reimbursement for your participation. If interested, please follow the study link to find out more about the specific study.

  • Studies Currently Open

    TRH Phase I (SPARK)

    Psychiatry Repository

    VDOT Study (NARSAD/Brain & Behavior Research Foundation)

  • Planned Future Studies

    RGH-MD-24 (Allergan Inc.)

    • A Double-Blind, Placebo-Controlled, Randomized Withdrawal, Multicenter Clinical Trial Evaluating the Efficacy, Safety, and Tolerability of Cariprazine in a Dose-Reduction Paradigm in the Prevention of Relapse in Patients with Schizophrenia
    • Principal Investigator: Jayesh Kamath, M.D., Ph.D.

    Depression & mHealth Study (National Institutes of Health)

    • Personalized Depression Treatment Supported by Mobile Sensor Analytics
    • Principal Investigator: Bing Wang, Ph.D.; Co-Principal Investigator: Jayesh Kamath, M.D., Ph.D.

    Suvorexant & mHealth Sleep Study (Merck Inc.)

    • Investigation of a Novel Mobile Health (mHealth) Technology Approach to Investigate Sleep Effects and Daytime Functioning in Depressed Patients with Comorbid Insomnia Receiving Co-administration of Suvorexant and an Antidepressant
    • Principal Investigator: Jayesh Kamath, M.D., Ph.D.
  • Completed Studies

    STAIR PTSD Study (National Institute of Mental Health)

    • Implementation of an Evidence Based PTSD Treatment in Public Sector Settings
    • Principal Investigator: Jayesh Kamath, M.D., Ph.D.

    Texting CIG (CICATS)

    • A Text Messaging Intervention to Improve Psychiatric Treatment Adherence: A Proof-of-Principle Study
    • Principal Investigator: Jayesh Kamath, M.D., Ph.D.

    FIRST Study (Janssen Inc.)

    • Family Intervention in Recent onset Schizophrenia Treatment (FIRST)
    • A 12-Month Randomized, Open-Label Study of Caregiver Psychoeducation and Skills Training in Patients Recently Diagnosed with Schizophrenia, Schizoaffective Disorder, or Schizophreniform Disorder and Receiving Paliperidone Palmitate or Oral Antipsychotic Treatment
    • Principal Investigator: Jayesh Kamath, M.D., Ph.D.

    ASPIRE-2 (Janssen Inc.)

    • A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Subjects Assessed to Be at Imminent Risk for Suicide
    • Principal Investigator: Jayesh Kamath, M.D., Ph.D.

    LifeRhythm Study (National Science Foundation)

    • LifeRhythm: A Framework for Automatic and Pervasive Depression Screening Using Smartphones
    • Principal Investigator: Bing Wang, Ph.D.; Co-Principal Investigator: Jayesh Kamath, M.D., Ph.D.

Behavioral and Mental Health

Want To Make an Appointment?